Performance of 0/1 h versus 0/3 h pathways in patients with suspected myocardial infarction: a systematic review and individual participant data meta-analysis of randomised controlled trials.

Boeddinghaus J, Kunz M, Lopez-Ayala P, Khand A, Inoue K, Hatherley J, Miller J, Lambrakis K, Emakhu J, Cook B, Collinson P, Papendick C, Kasim S, Salleh FM, Wiencierz A, Bima P, Crisanti L, Koechlin L, Christ M, Miró Ò, Morello F, Nazerian P, Abubakr M, Roth D, Mahfoud F, Riley R, McCord J, Chew DP, Mueller C, Global 0/1 h Consortium.

Open source

DOI
10.1016/s0140-6736(26)01767-8
Published
2026-10-29
Container
Lancet
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-01767-8,
  title = {Performance of 0/1 h versus 0/3 h pathways in patients with suspected myocardial infarction: a systematic review and individual participant data meta-analysis of randomised controlled trials.},
  author = {Boeddinghaus J and  Kunz M and  Lopez-Ayala P and  Khand A and  Inoue K and  Hatherley J and  Miller J and  Lambrakis K and  Emakhu J and  Cook B and  Collinson P and  Papendick C and  Kasim S and  Salleh FM and  Wiencierz A and  Bima P and  Crisanti L and  Koechlin L and  Christ M and  Miró Ò and  Morello F and  Nazerian P and  Abubakr M and  Roth D and  Mahfoud F and  Riley R and  McCord J and  Chew DP and  Mueller C and  Global 0/1 h Consortium.},
  year = {2026},
  journal = {Lancet},
  doi = {10.1016/s0140-6736(26)01767-8},
  url = {https://doi.org/10.1016/s0140-6736(26)01767-8}
}

RIS

TY  - JOUR
TI  - Performance of 0/1 h versus 0/3 h pathways in patients with suspected myocardial infarction: a systematic review and individual participant data meta-analysis of randomised controlled trials.
AU  - Boeddinghaus J
AU  -  Kunz M
AU  -  Lopez-Ayala P
AU  -  Khand A
AU  -  Inoue K
AU  -  Hatherley J
AU  -  Miller J
AU  -  Lambrakis K
AU  -  Emakhu J
AU  -  Cook B
AU  -  Collinson P
AU  -  Papendick C
AU  -  Kasim S
AU  -  Salleh FM
AU  -  Wiencierz A
AU  -  Bima P
AU  -  Crisanti L
AU  -  Koechlin L
AU  -  Christ M
AU  -  Miró Ò
AU  -  Morello F
AU  -  Nazerian P
AU  -  Abubakr M
AU  -  Roth D
AU  -  Mahfoud F
AU  -  Riley R
AU  -  McCord J
AU  -  Chew DP
AU  -  Mueller C
AU  -  Global 0/1 h Consortium.
PY  - 2026
JO  - Lancet
DO  - 10.1016/s0140-6736(26)01767-8
UR  - https://doi.org/10.1016/s0140-6736(26)01767-8
ER  - 

APA

J, B., M, K., P, L., A, K., K, I., J, H., J, M., K, L., J, E., B, C., P, C., C, P., S, K., FM, S., A, W., P, B., L, C., L, K., M, C., Ò, M., F, M., P, N., M, A., D, R., F, M., R, R., J, M., DP, C., C, M., & Consortium., G. 0. H. (2026). Performance of 0/1 h versus 0/3 h pathways in patients with suspected myocardial infarction: a systematic review and individual participant data meta-analysis of randomised controlled trials.. Lancet. https://doi.org/10.1016/s0140-6736(26)01767-8

Source records